Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Latest news

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • General
  • Media
  • News

Rite Aid Forges Path To Financial Recovery With Major Settlement: Report

By Shivani Kumaresan
March 27, 5:54 AM
Rite Aid (OTC: RADCQ) settles with lenders and DOJ, marking a crucial step toward bankruptcy resolution by April, Reuters reports. Attorney Aparna Yenamandra highlights broad stakeholder agreement, signaling progress despite remaining complexities. Junior bondholders, including Brigade Capital Management, express caution.

MCK

Read More
1 minute read
  • General
  • Health Care
  • Large Cap
  • Legal
  • News
  • Penny Stocks

Privacy Risks Flagged: Major Pharmacy Chains Share Customer Data With Authorities Without Warrant

By Vandana Singh
December 13, 9:58 AM
A congressional review of some major pharmacy chains' privacy practices found that none require a warrant before sharing customers' records with law enforcement.

AMZN

Read More
2 minute read
  • General
  • Health Care
  • Legal
  • Media
  • News
  • Penny Stocks

Drugstore Chain Rite Aid Counters DOJ Lawsuit Amid Bankruptcy, Aiming To Safeguard Restructuring

By Vandana Singh
November 17, 8:37 AM
Rite Aid Corp (OTC: RADCQ), currently undergoing bankruptcy proceedings, has reportedly taken a legal stance against the U.S.

RADCQ

Read More
2 minute read
  • Equities
  • General
  • Health Care
  • Markets
  • News
  • Penny Stocks

Could Your Eye Drops Be Unsafe? FDA Flags Amazon For Distributing Risky Eye Products, Demands Immediate Action

By Nabaparna Bhattacharya
November 15, 7:19 AM
Amazon.Com, Inc. (NASDAQ: AMZN) has received a 

AMZN

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • News
  • Penny Stocks

GSK’s Competitive Edge, Surpasses Pfizer in Respiratory Syncytial Virus Vaccine Sales

By Vandana Singh
October 30, 11:48 AM
GSK (NYSE: GSK) has reportedly taken an early lead in the race for respiratory syncytial virus (RSV) vaccine dominance, surpassing Pfizer Inc (NYSE: PFE), which previously dominated the COVID-19 vaccine market.

CVS

Read More
1 minute read
  • Equities
  • General
  • Markets
  • Media
  • News
  • Penny Stocks

‘Pharmageddon’ – Thousands Of Pharmacists Plan Walkout To Protest Work Conditions: Report

By Shivani Kumaresan
October 30, 11:22 AM
Beginning Monday, pharmacy employees from leading chains such as CVS Health Corp (NYSE: CVS), Walgreens Boots Alliance, Inc. (NASDAQ: WBA), and Rite Aid Corp (OTC:

CVS

Read More
2 minute read
  • FDA
  • General
  • Health Care
  • Large Cap
  • News
  • Penny Stocks

Risk of Eye Infection – FDA Issues Strong Warning on Eye Drops from Major Retailers

By Vandana Singh
October 30, 9:34 AM
On Friday, the FDA issued a warning to consumers, cautioning them against the use of certain over-the-coun

CAH

Read More
2 minute read
  • Equities
  • General
  • Health Care
  • Markets
  • News
  • Penny Stocks

Are Your Eyes At Grave Risk? FDA Issues Dangerous Warning Over Popular Drops From CVS, Target, Cardinal Health And More

By Nabaparna Bhattacharya
October 28, 12:49 PM
The U.S.

BHC

Read More
1 minute read
  • Equities
  • General
  • Legal
  • Markets
  • Media
  • News
  • Penny Stocks

Walgreens Agrees To Pay $192.5M To Resolve Rite Aid Buyout Suit: Report

By Shivani Kumaresan
October 19, 1:05 PM
Walgreens Boots Alliance Inc (NASDAQ: WBA) has reportedly consented to a settlement of $192.5 million following allegations that some of the company's executives provided misleading information concerning its 2015 attempt to purchase Rite Aid Corp. (OTC:

RADCQ

Read More
2 minute read
  • Financing
  • News

Rite Aid Receives Court Approval Of “First Day” Motions To Support Business Operations; Secures Interim Approval To Access Up To $3.45B In Debtor-In-Possession Financing

By Benzinga Newsdesk
October 17, 11:07 AM
Secures Interim Approval to Access Up to $3.45 Billion in Debtor-in-Possession FinancingContinues to Serve Customers and Deliver Healthcare Products and Services Across Retail and Online PlatformsRite Aid Corporation

RAD

Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service